Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc

INTRODUCTION: Nucleoside reverse transcriptase inhibitor (NRTI) is associated with endothelial dysfunction and proinflammatory effects. Maraviroc (MVC) is an antagonist of CCR5 receptor. CCR5 is the receptor of RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted), a mediator of chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal, Enrique, Miguel Gomez Verdú, Jose, Vera, Francisco, Martinez, Onofre, Bravo, Joaquin, Galera, Carlos, Muñoz, Angeles, Garcia, Eva, Serrano, Jose, Perez, Ana, Vera, Carmen, Marín, Irene, Cano, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P194
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225394/
https://www.ncbi.nlm.nih.gov/pubmed/25397472
http://dx.doi.org/10.7448/IAS.17.4.19726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225394/
https://www.ncbi.nlm.nih.gov/pubmed/25397472
http://dx.doi.org/10.7448/IAS.17.4.19726

Ejemplares similares